Johannes Wilhelm Bigalke

Title: The Innovations of Johannes Wilhelm Bigalke

Introduction

Johannes Wilhelm Bigalke is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in the study of neurotoxins. His work has implications for medical science and therapeutic applications.

Latest Patents

Bigalke holds a patent for a groundbreaking invention titled "Botulinum neurotoxin A protein receptor and uses thereof." This invention relates to an isolated polypeptide of the luminal domain of synaptic vesicle glycoprotein 2C, wherein at least 70 percent of the amino acid sequence is identical to the amino acid sequence of SV2C. The polypeptide is designed to bind the H fragment of botulinum neurotoxin A, provided that it is not the synaptic vesicle glycoprotein 2C.

Career Highlights

Bigalke is associated with Toxogen GmbH, a company that focuses on innovative solutions in the field of neurotoxin research. His work at Toxogen has positioned him as a key figure in advancing the understanding of neurotoxic proteins and their potential applications.

Collaborations

Throughout his career, Bigalke has collaborated with esteemed colleagues such as Stefan Mahrhold and Andreas Rummel. These collaborations have enriched his research and contributed to the development of new technologies in the field.

Conclusion

Johannes Wilhelm Bigalke's contributions to biotechnology, particularly through his patent on botulinum neurotoxin A, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the field and pave the way for future discoveries.